Review estimates acne risk with JAK inhibitor therapyNovember 9, 2023AcnePsoriasisAtopic DermatitisPsoriatic ArthritisHair & NailsDermatologyGastroenterology
FDA approves bimekizumab for moderate to severe plaque psoriasis in adultsOctober 19, 2023PsoriasisPsoriatic ArthritisDermatology
Study validates use of new psoriatic arthritis prediction toolAugust 11, 2023PsoriasisPsoriatic ArthritisDermatologyRheumatology
Psoriasis, psoriatic arthritis insurance coverage remains restrictiveSeptember 26, 2022Psoriatic ArthritisPsoriasisDermatologyRheumatology
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?September 8, 2022Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriasisRheumatology
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisPsoriasis
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisDermatologyRheumatologyPsoriasis
Proactive infliximab monitoring found best for sustaining control of inflammatory diseasesJanuary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathiesGastroenterologyDermatologyRheumatology
Better COVID-19 outcomes confirmed in TNF inhibitor usersOctober 22, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisPsoriasisGastroenterology
Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findingsOctober 13, 2021Psoriatic ArthritisPsoriasisRheumatologyDermatology
European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitisPsoriasisMusculoskeletal Disorders
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains highSeptember 15, 2021PsoriasisPsoriatic ArthritisDermatologyRheumatology
Psoriatic arthritis health care costs continue to rise over timeAugust 24, 2021Psoriatic ArthritisRheumatologyPsoriasis
Physicians question the future of TNF inhibitors for psoriasis, PsAAugust 6, 2021Psoriatic ArthritisPsoriasisRheumatologyDermatology
Researchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitisRheumatology
